What is the Impact Factor of Molecular Pharmaceutics?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Molecular Pharmaceutics is 4.90, ranking in quartile Q2 of Web of Science (SCIE).

Is Molecular Pharmaceutics indexed in Web of Science or Scopus?

Yes, Molecular Pharmaceutics is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.957 (Q1) and an H-index of 172.

Who publishes Molecular Pharmaceutics and what is the Article Processing Charge (APC)?

Molecular Pharmaceutics is published by American Chemical Society. The estimated Article Processing Charge (APC) is approximately $3,295 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Molecular Pharmaceutics?

The official ISO-4 abbreviation of Molecular Pharmaceutics is "MOL. PHARMACEUTICS" with common acronym "acs". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #5,243Hybrid

Molecular Pharmaceutics

Acronym:acs

•

Abbreviation (ISO):MOL. PHARMACEUTICS

•

Identifier (ISSN):1543-8384(Print)/1543-8392(Online)

•

Publisher:American Chemical Society

Official Website Submission Portal Compare

Clarivate IF (2026)

4.9↑ +0.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Molecular Pharmaceutics

WoS Q2

Annual Impact Factor Metric

Current (2026):4.9

Scopus SJR & RankScopus Q1

0.957

#5,243

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

172

172 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate6.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

384articles/year

20.04% Gold OA•92.05% Original Research

Aims & Scope

Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.

Topics Covered (Recognized by AI)

Chemistry96.1%Biology93%Medicine81.4%Biochemistry78.1%Genetics74.3%Organic chemistry62.3%Internal medicine58.8%Physics57.1%Materials science49.9%Pharmacology48.8%Engineering38.4%Quantum mechanics33%Chemical engineering32.9%Nanotechnology31%In vitro30.4%Nuclear magnetic resonance30%Psychology29.9%Biotechnology27.2%Gene26.4%In vivo25.5%Immunology23.8%Psychiatry22.8%Composite material20.8%Endocrinology20.7%Cell biology20.4%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank52/191

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank74/356

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank41/191

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank61/356

IndexSCIE

Category	Index	Rank	Quartile
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	52/191	Q2
PHARMACOLOGY & PHARMACY	JCRSCIE	74/356	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	41/191	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	61/356	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.9

Articles / Year367

Total Citations226

2025

IF4.5

Articles / Year646

Total Citations2,532

2024

IF4.5

Articles / Year551

Total Citations5,246

2023

IF4.9

Articles / Year517

Total Citations7,405

2022

IF5.364

Articles / Year467

Total Citations8,463

Year	Impact Factor	Articles / Year	Total Citations
2026	4.9	367	226
2025	4.5	646	2,532
2024	4.5	551	5,246
2023	4.9	517	7,405
2022	5.364	467	8,463
2021	4.939	382	9,922
2020	4.321	436	12,910
2019	4.396	496	17,221
2018	4.556	567	22,852
2017	—	481	19,127
2016	—	418	18,937
2015	—	465	22,990

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,243Scopus Q1SCImago Profile

Scopus Coverage:2004-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.957

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.86

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,295 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations7,218

3-Year Documents1,434

Citable Documents1,362

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate41.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1

Drug DiscoveryQ2

Molecular MedicineQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区MEDICINE, RESEARCH & EXPERIMENTAL

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Pharmaceutics (acronym: acs, abbr: MOL. PHARMACEUTICS, ISSN: 1543-8384) is a peer-reviewed international scholarly journal in the field of Medicine, published by American Chemical Society in United States since 2004. The periodical holds a Journal Impact Factor (JIF) of 4.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.957 (Q1), an H-index of 172.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 384 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,295 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.